SCHEMBL6987676

SCHEMBL6987676

CC(C)(CNCCc1ccccc1)OC(=O)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
NPC1 O15118 3/20 0.49
TDP1 Q9NUW8 1/20 0.49
HTT P42858 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
OPRM1 P35372 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
CYP2D6 P10635 3/20 0.45
SIGMAR1 Q99720 2/20 0.45
TAAR1 Q96RJ0 2/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
STS P08842 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
ATM Q13315 1/20 0.42
NAAA Q02083 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7382762 0.81 PREP (0.48) GAANPC1HTTRAB9ASMN1; SMN2
SCHEMBL7367008 0.79 PREP (0.48) GAANPC1HTTRAB9ASMN1; SMN2
SCHEMBL8539666 0.77 MEN1 (0.43) NPC1TDP1HTTRAB9ASMN1; SMN2
SCHEMBL24641500 0.75 SMN1; SMN2 (0.59) GAAHTTSMN1; SMN2MEN1KMT2A
SCHEMBL6646692 0.75 DPP7 (0.45) GAASMN1; SMN2KMT2AALDH1A1STS
SCHEMBL8526553 0.74 SIGMAR1 (0.59) OPRM1SIGMAR1KMT2AALDH1A1KDM4E
Benzylamine SCHEMBL8028466 0.74 STS (0.51) GAASMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL4713703 0.73 HPGD (0.50) NPC1TDP1HTTRAB9ASMN1; SMN2
SCHEMBL24641798 0.73 GPR119 (0.50) GAAHTTSMN1; SMN2MEN1KMT2A
SCHEMBL30017169 0.73 GPR119 (0.50) GAAHTTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289957-A1 PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY AstraZeneca AB (SE) 2003-03-12 EP disclosed
WO-2001087839-A1 PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES, IN PARTICULAR AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA AB (SE) 2001-11-22 WO disclosed